{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:02:44Z","timestamp":1792105364527,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011008","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000}}],"reference-count":87,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011008.pub2","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T13:14:20Z","timestamp":1459602860000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness"],"prefix":"10.1002","volume":"2019","author":[{"given":"Hayley","family":"Barnes","sequence":"first","affiliation":[{"name":"Alfred Health; Department of Allergy, Immunology and Respiratory Medicine; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"McDonald","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network; Department of Supportive Care; Toronto Ontario Canada"},{"name":"Department of Medicine, University of Toronto; Division of Medical Oncology; Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Smallwood","sequence":"additional","affiliation":[{"name":"Royal Melbourne Hospital; Department of Respiratory Medicine; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Manser","sequence":"additional","affiliation":[{"name":"and Department of Respiratory Medicine, Royal Melbourne Hospital; Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, St Andrew's Place, East Melbourne 3002, Victoria; 305 Grattan Street Melbourne Australia 3000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"issue":"7414","key":"10.1002\/14651858.CD011008.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","article-title":"Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea","volume":"327","author":"Abernethy","year":"2003","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD011008.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jpm.2007.9912","article-title":"Can we predict which patients with refractory dyspnea will respond to opioids?","volume":"10","author":"Currow","year":"2007","journal-title":"Journal of Palliative Medicine"},{"issue":"22","key":"10.1002\/14651858.CD011008.pub2-BIB0003|cit3","first-page":"1363-4","article-title":"Breathlessness, alcohol and opiates","volume":"306","author":"Bar-Or","year":"1982","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011008.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-119-9-199311010-00007","article-title":"Subcutaneous morphine for dyspnea in cancer patients","volume":"119","author":"Bruera","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpainsymman.2007.08.016","article-title":"Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline","volume":"36","author":"Charles","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0735-1097(96)00446-9","article-title":"Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure","volume":"29","author":"Chua","year":"1997","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0007|cit7","first-page":"64-5","article-title":"Single dose randomised controlled trial of nebulised morphine in patients with cancer related breathlessness","volume":"10","author":"Davis","year":"1996","journal-title":"Palliative Medicine"},{"issue":"8","key":"10.1002\/14651858.CD011008.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1183\/09031936.93.04080926","article-title":"Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the \"pink puffer\" syndrome","volume":"4","author":"Eiser","year":"1991","journal-title":"European Respiratory Journal"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD011008.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0761-8425(04)71583-1","article-title":"Dyspnea and morphine aerosols in the palliative care of lung cancer","volume":"21","author":"Grimbert","year":"2004","journal-title":"Revue des Maladies Respiratoires"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1164\/ajrccm.152.6.8520759","article-title":"Low-dose nebulized morphine does not improve exercise in interstitial lung disease","volume":"152","author":"Harris-Eze","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0011|cit11","first-page":"S191","article-title":"Prophylactic subcutaneous fentanyl for exercise-induced breakthrough dyspnea: a preliminary double-blind, randomized controlled trial","volume":"21","author":"Hui","year":"2013","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"10.1002\/14651858.CD011008.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpainsymman.2013.03.017","article-title":"Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial","volume":"47","author":"Hui","year":"2014","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1002\/14651858.CD011008.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2270-4","DOI":"10.1183\/09031936.97.10102270","article-title":"Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease","volume":"10","author":"Jankelson","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpainsymman.2011.05.007","article-title":"Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease","volume":"43","author":"Jensen","year":"2012","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6366","key":"10.1002\/14651858.CD011008.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"675-7","DOI":"10.1136\/bmj.286.6366.675","article-title":"Dihydrocodeine for breathlessness in \u201cpink puffers\u201d","volume":"286","author":"Johnson","year":"1983","journal-title":"British Medical Journal (Clinical Research Edition)"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"753-6","DOI":"10.1016\/S1388-9842(02)00158-7","article-title":"Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study","volume":"4","author":"Johnson","year":"2002","journal-title":"European Journal of Heart Failure"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"596-600","DOI":"10.1136\/thx.51.6.596","article-title":"Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease","volume":"51","author":"Leung","year":"1996","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"975-81","DOI":"10.1378\/chest.109.4.975","article-title":"Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD","volume":"109","author":"Light","year":"1996","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"629-34","DOI":"10.1136\/thx.50.6.629","article-title":"Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease","volume":"50","author":"Masood","year":"1995","journal-title":"Thorax"},{"issue":"12","key":"10.1002\/14651858.CD011008.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1023\/A:1008337624200","article-title":"The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial","volume":"10","author":"Mazzocato","year":"1999","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpainsymman.2006.12.002","article-title":"Midazolam as adjunct therapy to morphine to relieve dyspnea? Authors' reply","volume":"33","author":"Cerchietti","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD011008.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jpainsymman.2009.10.003","article-title":"Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated","volume":"39","author":"Navigante","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD011008.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1079-83","DOI":"10.1183\/09031936.97.10051079","article-title":"Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine","volume":"10","author":"Noseda","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD011008.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ahj.2012.05.003","article-title":"Minimally clinically important difference in chronic breathlessness: every little helps","volume":"164","author":"Oxberry","year":"2012","journal-title":"American Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD011008.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1006-12","DOI":"10.1093\/eurjhf\/hfr068","article-title":"Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial","volume":"13","author":"Oxberry","year":"2011","journal-title":"European Journal of Heart Failure"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1877-80","DOI":"10.1164\/ajrccm.157.6.9711061","article-title":"The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease","volume":"157","author":"Poole","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0027|cit27","first-page":"287-92","article-title":"Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction","volume":"81","author":"Rice","year":"1987","journal-title":"British Journal of Diseases of the Chest"},{"issue":"9","key":"10.1002\/14651858.CD011008.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/heart.89.9.1085","article-title":"Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure","volume":"89","author":"Williams","year":"2003","journal-title":"Heart"},{"issue":"27","key":"10.1002\/14651858.CD011008.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1611-6","DOI":"10.1056\/NEJM198112313052703","article-title":"Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases","volume":"305","author":"Woodcock","year":"1981","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011008.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"387-90","DOI":"10.1136\/thx.44.5.387","article-title":"Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease","volume":"44","author":"Young","year":"1989","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"256-65","DOI":"10.1016\/S0885-3924(98)00157-2","article-title":"How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial","volume":"17","author":"Allard","year":"1999","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"175-8","DOI":"10.1378\/chest.104.1.175","article-title":"Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient","volume":"104","author":"Beauford","year":"1993","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpainsymman.2004.08.016","article-title":"Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study","volume":"29","author":"Bruera","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0034|cit34","first-page":"14","article-title":"Morphine plus midazolam versus oxygen therapy on severe dyspnea management in the last week of life in hipoxemic advanced cancer patients","volume":"10","author":"Navigante","year":"2003","journal-title":"Medicina Paliativa"},{"issue":"5","key":"10.1002\/14651858.CD011008.pub2-BIB0035|cit35","first-page":"545-7","article-title":"Pilot study of nebulised morphine for dyspnoea in palliative care patients","volume":"26","author":"Peterson","year":"1996","journal-title":"Australian Journal of Hospital Pharmacy"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"610921","DOI":"10.1155\/2012\/610921","article-title":"Effect of nebulized morphine on dyspnea of mustard gas-exposed patients: a double-blind randomized clinical trial study","volume":"2012","author":"Shohrati","year":"2012","journal-title":"Pulmonary Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011008.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/jpm.2009.0113","article-title":"Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned","volume":"12","author":"Smith","year":"2009","journal-title":"Journal of Palliative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0038|cit38","first-page":"242","article-title":"Methylnaltrexone, a peripheral opioid antagonist for opioid-induced constipation in advanced illness: an analysis of dyspnea in patients with chronic obstructive pulmonary disease (COPD) in two double-blind randomized trials. 18th International Congress on Palliative Care; Oct 5-8, 2010; Montreal","volume":"26","author":"Thomas","year":"2010","journal-title":"Journal of Palliative Care"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0039|cit39","first-page":"569","article-title":"A randomized cross-over clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer","volume":"26","author":"Cuervo Pinna","year":"2012","journal-title":"Palliative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011008.pub2-BIB0040|cit40","first-page":"e193","article-title":"Effect of lorazepam versus morphine on quality of life in hospice patients with dyspnea and anxiety","volume":"54","author":"Daubert","year":"2014","journal-title":"Journal of the American Pharmacists Association"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/ajrccm.159.1.ats898","article-title":"Dyspnea. Mechanisms, assessment, and management: a consensus statement","volume":"159","author":"American Thoracic Society","year":"1999","journal-title":"Amercan Journal of Respiratory and Critical Care Medicine"},{"issue":"10","key":"10.1002\/14651858.CD011008.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/00001756-200007140-00012","article-title":"Breathlessness in humans activate the insular cortex","volume":"11","author":"Banzett","year":"2000","journal-title":"NeuroReport"},{"issue":"2","key":"10.1002\/14651858.CD011008.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005623.pub2","article-title":"Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases","author":"Bausewein","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0044|cit44","first-page":"1","article-title":"The genesis of breathlessness - what do we understand?","volume-title":"Dyspnoea in Advanced Disease - A Guide to Clinical Management","author":"Beach","year":"2006"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1152\/jappl.1987.62.3.1046","article-title":"Medullary inspiratory activity: influence of intercostal tendon organs and muscle spindle endings","volume":"62","author":"Bolser","year":"1987","journal-title":"Journal of Applied Physiology"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1152\/jappl.1988.64.6.2458","article-title":"Respiratory pattern changes produced by intercostal muscle\/rib vibration","volume":"64","author":"Bolser","year":"1988","journal-title":"Journal of Applied Physiology"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.98.4.2029","article-title":"Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air","volume":"98","author":"Brannan","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18773\/austprescr.1996.063","article-title":"Opioids - mechanisms of action","volume":"19","author":"Chahl","year":"1996","journal-title":"Australian Prescriber"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004769.pub2","article-title":"Oxygen therapy for dyspnoea in adults","author":"Cranston","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpainsymman.2010.11.021","article-title":"Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study","volume":"42","author":"Currow","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0885-3924(98)00065-7","article-title":"Dyspnea in the advanced cancer patient","volume":"16","author":"Dudgeon","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1152\/jn.2002.88.3.1500","article-title":"BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger","volume":"88","author":"Evans","year":"2002","journal-title":"Journal of Neurophysiology"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0055|cit55","first-page":"313","article-title":"Reflex response to chemoreceptor stimulation","volume-title":"Handbook of Physiology, Section 3: The Respiratory System, Vol. 2. Control of Breathing","author":"Fitzgerald","year":"1986"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0056|cit56","unstructured":"McMaster University (developed by Evidence Prime, Inc.). Available from www.gradepro.org GRADEpro Guideline Development Tool [Software] 2015"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0034-5687(97)00050-9","article-title":"Brain, breathing and breathlessness","volume":"109","author":"Guz","year":"1997","journal-title":"Respiration Physiology"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0058|cit58","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"11","key":"10.1002\/14651858.CD011008.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1073\/pnas.98.4.2035","article-title":"Brain responses associated with consciousness of breathlessness (air hunger)","volume":"98","author":"Liotti","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1378\/chest.09-1543","article-title":"American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease","volume":"137","author":"Mahler","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD011008.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/ers.13.5","article-title":"Opioids for refractory dyspnoea","volume":"7","author":"Mahler","year":"2013","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"23","key":"10.1002\/14651858.CD011008.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM199512073332307","article-title":"Pathophysiology of dyspnea","volume":"333","author":"Manning","year":"1995","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2125.1996.tb00192.x","article-title":"Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects","volume":"41","author":"Masood","year":"1996","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6132","key":"10.1002\/14651858.CD011008.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"241-3","DOI":"10.1136\/bmj.2.6132.241","article-title":"Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease","volume":"2","author":"McGavin","year":"1978","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0067|cit67","first-page":"473","article-title":"Central chemoreceptors","volume-title":"Regulation of Breathing","author":"Nattie","year":"1995"},{"issue":"10","key":"10.1002\/14651858.CD011008.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.rmed.2006.01.016","article-title":"Dyspnea in relation to symptoms of anxiety and depression: a prospective population study","volume":"100","author":"Neuman","year":"2006","journal-title":"Respiratory Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/bja\/aer040","article-title":"Dyspnoea: underlying mechanisms and treatment","volume":"106","author":"Nishino","year":"2011","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD011008.pub2-BIB0071|cit71","first-page":"1557-65","article-title":"Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease","volume":"158","author":"O\u2019Donnell","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1043","key":"10.1002\/14651858.CD011008.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/postgradmedj-2011-000074rep","article-title":"Attitudes to morphine in chronic heart failure patients","volume":"88","author":"Oxberry","year":"2012","journal-title":"Postgraduate Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","article-title":"An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea","volume":"185","author":"Parshall","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.98.4.2041","article-title":"Neuroimaging evidence implicating cerebellum in the experience of hypercapnia and hunger for air","volume":"98","author":"Parsons","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"25","key":"10.1002\/14651858.CD011008.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1523\/JNEUROSCI.1375-09.2009","article-title":"Opioids depress cortical centers responsible for the volitional control of respiration","volume":"29","author":"Pattinson","year":"2009","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD011008.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/ajrccm.163.4.2005057","article-title":"Neural substrates for the perception of acutely induced dyspnea","volume":"163","author":"Peiffer","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5560","key":"10.1002\/14651858.CD011008.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.1067176","article-title":"Placebo and opioid analgesia-- imaging a shared neuronal network","volume":"295","author":"Petrovic","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002872","article-title":"Nebulised morphine for severe interstitial lung disease","author":"Polosa","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0079|cit79","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"9","key":"10.1002\/14651858.CD011008.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1503\/cmaj.111758","article-title":"Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease","volume":"184","author":"Rocker","year":"2012","journal-title":"Canadian Medical Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007354.pub2","article-title":"Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults","author":"Simon","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011008.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006429.pub2","article-title":"Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease","author":"Uronis","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011008.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuroimage.2009.06.015","article-title":"Dyspnoea and pain share emotion-related brain network","volume":"48","author":"Leupoldt","year":"2009","journal-title":"NeuroImage"},{"key":"10.1002\/14651858.CD011008.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1242\/jeb.100.1.41","article-title":"Pulmonary and respiratory tract receptors","volume":"100","author":"Widdicombe","year":"1982","journal-title":"Journal of Experimental Biology"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0085|cit85","first-page":"137","article-title":"Chronic refractory dyspnoea--evidence based management","volume":"42","author":"Wiseman","year":"2013","journal-title":"Australian Family Physician"},{"issue":"23","key":"10.1002\/14651858.CD011008.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0024-3205(00)00434-3","article-title":"Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea","volume":"66","author":"Zebraski","year":"2000","journal-title":"Life Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011008.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002066","article-title":"Opioids for the palliation of breathlessness in advanced disease and terminal illness","author":"Jennings","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011008.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:53:42Z","timestamp":1692276822000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011008.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":87,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011008.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}